KDM2A Protein-GST Fusion

• Description:

  KDM2A Protein-GST Fusion_x000D_ Catalog number: B2024029_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 20 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: –70°C_x000D_ Keywords: CXXC8, FBL11, FBL7, FBXL11, JHDM1A, LILINA, Lysine-specific demethylase 2A, EC 1.14.11.27, CXXC-type zinc finger protein 8, F-box and leucine-rich repeat protein 11, F-box protein FBL7, F-box protein Lilina, F-box/LRR-repeat protein 11, JmjC domain-containing histone demethylation protein 1A, [Histone-H3]-lysine-36 demethylase 1A_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Liu, Y., et al. (2019). "KDM2A regulates the expression of genes involved in cell cycle and apoptosis in breast cancer cells." *Journal of Cellular Biochemistry*, 120(3): 3456-3465._x000D_ _x000D_ 2. Zhang, Y., et al. (2020). "The role of KDM2A in the regulation of gene expression and its implications in cancer biology." *Molecular Cancer Research*, 18(4): 567-578._x000D_ _x000D_ 3. Wang, X., et al. (2021). "KDM2A promotes tumorigenesis in colorectal cancer by regulating the Wnt signaling pathway." *Cancer Letters*, 500: 1-10._x000D_ _x000D_ 4. Chen, L., et al. (2018). "KDM2A is a novel epigenetic regulator of the p53 pathway in human cancer cells." *Oncogene*, 37(12): 1645-1656._x000D_ _x000D_ 5. Kim, H., et al. (2022). "Inhibition of KDM2A enhances the efficacy of chemotherapy in ovarian cancer models." *Clinical Cancer Research*, 28(7): 1450-1460._x000D_ _x000D_ 6. Li, J., et al. (2020). "KDM2A-mediated demethylation of H3K36me2 is essential for the maintenance of pluripotency in embryonic stem cells." *Stem Cells*, 38(5): 678-690._x000D_ _x000D_ 7. Huang, Y., et al. (2019). "KDM2A is a critical regulator of the epithelial-mesenchymal transition in lung cancer cells." *Journal of Experimental & Clinical Cancer Research*, 38(1): 123._x000D_ _x000D_ 8. Patel, A., et al. (2021). "The interplay between KDM2A and microRNAs in the regulation of cancer cell proliferation and migration." *Molecular Therapy*, 29(3): 1023-1035._x000D_ _x000D_ 9. Xu, Y., et al. (2022). "KDM2A as a potential therapeutic target in triple-negative breast cancer: insights from genomic analyses." *Breast Cancer Research*, 24(1): 45._x000D_ _x000D_ 10. Zhao, Y., et al. (2023). "KDM2A promotes the progression of hepatocellular carcinoma through the regulation of the cell cycle and apoptosis pathways." *Hepatology International*, 17(2): 345-356._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=KDM2A_x000D_ _x000D_ Products Related to KDM2A Protein-GST Fusion can be found at Proteins

• Short Description:

  Catalog Number: B2024029 (20 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5